Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 1996, for Philip Morris Companies Inc. (Note: The request metadata listed "Altria Group," but the filing text identifies the registrant as Philip Morris Companies Inc., the predecessor to Altria). The company operates primarily in consumer products (Tobacco, Food, Beer) and Financial Services/Real Estate.
Key Financial Metrics
| Metric | Q1 1996 | Q1 1995 |
|---|---|---|
| Operating Revenues | $17,491 million | $16,517 million |
| Operating Income | $2,929 million | $2,648 million |
| Net Earnings | $1,565 million | $1,335 million |
| Earnings Per Share (Diluted) | $1.89 | $1.57 |
| Cash from Operating Activities | $614 million | $407 million |
| Total Debt | $16,700 million | $15,800 million (Dec 31, 1995) |
| Cash and Cash Equivalents | $680 million | $1,138 million (Dec 31, 1995) |
Material Changes vs. Prior Period
- Revenue Growth: Operating revenues increased 5.9% ($974 million) year-over-year, driven by growth in Tobacco, International Food, and Beer segments. Excluding divested food businesses, revenue growth was 12.6%.
- Profitability: Operating income rose 10.6% ($281 million). Net earnings increased 14.8% ($202 million), aided by lower interest expense and a reduction in shares outstanding due to buybacks.
- Segment Performance:
- Tobacco: Domestic revenues up 9.9% (volume +6.7%, pricing +$75M); International revenues up 17.7% (volume +12.9%).
- Food: North American revenues down 14.5% due to divestitures; International revenues up 15.5%.
- Beer: Revenues up 5.2% due to price/mix improvements and volume growth.
- Currency Impact: Unfavorable currency movements (Japanese yen, Mexican peso) reduced operating income by $17 million.
Outlook, Risks, and Contingencies
- Regulatory Risks: The FDA has proposed regulations asserting jurisdiction over nicotine as a "drug" and cigarettes as "medical devices." The company is litigating to block these regulations, which could severely impact operations if upheld.
- Legal Contingencies: As of March 31, 1996, there were 156 smoking and health cases pending in the U.S., including class actions in Florida and Louisiana. Additionally, seven states have filed or are considering actions seeking Medicaid reimbursement for smoking-related costs. The company states it cannot estimate the potential loss but believes the ultimate outcome will not materially affect its financial position.
- Divestitures and Acquisitions: The company continues to divest non-core food businesses (e.g., Kraft Foodservice distribution) and acquired a controlling interest in ZPT-Krakow (Poland) in Q1 1996.
- Share Repurchases: The company repurchased 7.2 million shares for $685 million in Q1 1996. Cumulative purchases under the $6 billion program totaled 42.7 million shares ($3.2 billion) through March 31, 1996.
Investor Verification Checklist
- Verify the status of the FDA regulatory challenge and potential impact on future tobacco revenue.
- Monitor the progression of state Medicaid reimbursement lawsuits (e.g., Florida, Texas, Maryland) and the Liggett Group settlement precedent.
- Assess the impact of currency fluctuations on international earnings, particularly in Europe and Asia.
- Review the integration and performance of the newly acquired ZPT-Krakow tobacco operations in Poland.
- Confirm the sustainability of volume growth in the domestic tobacco segment given the industry's long-term decline trend.